GENOME ANNOUNCEMENT
===================

The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) *Mycobacterium tuberculosis* is a major public health problem that threatens tuberculosis (TB) care and control in many countries ([@B1]). XDR *Mycobacterium tuberculosis* strain UM 1072388579 was isolated from a 57-year-old man. The isolate was resistant to amikacin, capreomycin, ciprofloxacin, ethionamide, isoniazid, kanamycin, ofloxacin, rifampin, and streptomycin but sensitive to ethambutol and para-salicylic acid.

The genomic DNA of UM 1072388579 was sequenced to 240× coverage with a 500-bp insert size library strategy, which consisted of 5,861,112 paired-end reads, using the Illumina HiSeq 2000 sequencer machine. After preprocessing, 2,800,000 high-quality paired-end reads (100-fold depth) were subsampled and assembled using Velvet v1.1.07 ([@B2]), producing 213 contigs (≥200 bp). The contigs were then scaffolded and gap filled with SSPACE v2.0 ([@B3]) and GapFiller v1.10 ([@B4]) programs by utilizing all paired-end information available. Final assembly consisted of 89 scaffolds (≥1,000 bp) with 158 contigs comprising a total length of 4.3 Mb. The assembly has an N50 scaffold size of 108,779 bp and *G+C* content of 65.4%. Protein coding sequences, rRNAs, and tRNAs of the XDR *M. tuberculosis* genome were predicted using GeneMarkS ([@B5]), RNAmmer 1.2 server ([@B6]), and tRNAscan-SE v1.23 ([@B7]), respectively. Our pipeline predicted 4,099 coding DNA sequences (CDS) with length ≥33 amino acids (aa), 45 tRNAs, and 3 rRNAs (5S, 16S, and 23S). Annotation of the coding sequences predicted was performed by a BLAST search against the NCBI nonredundant database with 4,069 (99.3%) genes annotated with function. All annotated genes were subjected to Gene Ontology classification and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways analysis.

The genome sequence is about 93% complete compared to the F11 reference genome, which has a complete genome size of 4.42 Mb. A polymorphism study of the XDR *M. tuberculosis* genome was carried out by comparative analysis against the F11 genome ([@B8]) to identify the difference between intergenic and coding regions of drug-susceptible versus extensively drug-resistant strains. A total of 1,455 polymorphisms were observed in our comparative study, with 1,196 of these located in the coding regions of the genome. An insertion at the *tlyA* gene (a determinant for extensively drug-resistant *M. tuberculosis*) conferring capreomycin resistance to *M. tuberculosis* was observed. Mutations of other drug resistance sites such as *ethA* (ethionamide), *gidB* (streptomycin), *gyrA* and *gyrB* (fluoroquinolones), *pncA* (pyrazinamide), *katG* and *ndh* (isoniazid), and *rpoB* (rifampin) were also observed. The draft sequence of the XDR *M. tuberculosis* UM 1072388579 genome provides a genome sequence that may lead to better understanding of the genetic molecular differences in acquired drug resistance of XDR *M. tuberculosis* isolates locally and in other parts of the world.

Nucleotide sequence accession number.
-------------------------------------

The nucleotide sequences of the *M. tuberculosis* UM 1072388579 genome have been deposited in DDBJ/EMBL/GenBank under accession number [AMXW00000000](AMXW00000000).

**Citation** Ng KP, Yew SM, Chan CL, Chong J, Tang SN, Soo-Hoo TS, Na SL, Hassan H, Ngeow YF, Hoh CC, Lee KW, Yee WY. 2013. Draft genome sequence of the first isolate of extensively drug-resistant (XDR) *Mycobacterium tuberculosis* in Malaysia. Genome Announc. 1(1):e00056-12. doi:10.1128/genomeA.00056-12.

This study was supported by research grant UM.C/625/1/HIR/003/1 from the University of Malaya.

K.P.N., Y.F.N., and H.H. conceived the project and contributed to the writing and editing of the manuscript. K.P.N., J.C., S.N.T., T.S.S.H., C.L.C., and S.L.N. were responsible for the isolation, identification, and DNA extraction. S.M.Y., C.C.H., K.W.L., and W.Y.Y. performed the genome sequencing and bioinformatics analysis.
